Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
307
-
Total 13F shares, excl. options
-
73.3M
-
Shares change
-
+988K
-
Total reported value, excl. options
-
$4.13B
-
Value change
-
+$8.31M
-
Put/Call ratio
-
0.84
-
Number of buys
-
149
-
Number of sells
-
-156
-
Price
-
$56.37
Significant Holders of RESMED INC - COM (RMD) as of Q2 2015
376 filings reported holding RMD - RESMED INC - COM as of Q2 2015.
RESMED INC - COM (RMD) has 307 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.3M shares
.
Largest 10 shareholders include Capital Research Global Investors (11.4M shares), VANGUARD GROUP INC (9.87M shares), BlackRock Fund Advisors (4.9M shares), STATE STREET CORP (4.28M shares), FMR LLC (4.27M shares), BlackRock Institutional Trust Company, N.A. (4.02M shares), Bank of New York Mellon Corp (2.16M shares), COMMONWEALTH BANK OF AUSTRALIA (1.88M shares), Invesco Ltd. (1.52M shares), and FIRST TRUST ADVISORS LP (1.1M shares).
This table shows the top 307 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.